EXPERIENCE

Prior to joining Paul, Weiss, Matt’s recent experience includes:

M&A Transactions

• Abbvie in its withdrawn $55 billion acquisition of Shire
• AIG in the $15 billion sale of Alico to MetLife
• Amazon in its $14 billion acquisition of Whole Foods
• Amgen in its $10 billion acquisition of Onyx
• AT&T in numerous transactions, including in its:
  • $67 billion acquisition of DirecTV
  • $109 billion acquisition of Time Warner
  • $39 billion blocked acquisition of T-Mobile
• Bayer in its $66 billion acquisition of Monsanto
• Biohaven in its $12 billion sale to Pfizer
• Cablevision in its $18 billion sale to Altice
• Columbia Pipeline in its $13 billion sale to TransCanada
• Concho in its:
  • $13 billion sale to ConocoPhilips
  • $10 billion acquisition RSP Permian
• Credit Suisse in its $3 billion sale to UBS
• CVS in its $13 billion acquisition of Omnicare
• Dyax in its $6 billion sale to Shire
• Enbridge in its $43 billion acquisition of Spectra
• Fiat in its acquisition of Chrysler, in connection with its chapter 11 case
• Fiserv in its $22 billion acquisition of First Data
• Genomic Health in its $3 billion sale to Exact Sciences
• GGP in its $28 billion sale to Brookfield
• Goldman Sachs in its $6 billion acquisition of SLK
• Great-Wise Lifeco in its $2 billion sale of Putnam to Franklin Resources
• Harris in its $35 billion merger of equals with L3
• Management team of HCA in its $33 billion LBO by KKR and Bain
• Hilton Hotels in its $26 billion sale to Blackstone
• Idenix in its $4 billion sale to Merck
• ICE in its $8 billion acquisition of the NYSE
• Kite Pharma in its $12 billion sale to Gilead Sciences
• Kraft in its $55 billion merger with Heinz
• Medco in its $29 billion sale to Express Scripts
• Perrigo in its $9 billion acquisition of Elan
• Pharmasset in its $11 billion sale to Gilead Sciences
• PRA Health Sciences in its approximately $12 billion sale to ICON
• Priceline in its acquisitions of Kayak and OpenTable
• SBC in its $22 billion acquisition of AT&T
• Seagen in its $43 billion sale to Pfizer
• Silver Lake in its $9 billion sale of Skype to Microsoft
• Stemcentrx in its $10 billion sale to AbbVie
• Synageva in its $8 billion sale to Alexion
• Triton in its $13 billion sale to Brookfield Infrastructure
• TXO in its $45 billion sale to KKR and TPG
• UnitedHealth in its:
  • $13 billion acquisition of Catamaran
  • $14 billion acquisition of Change Healthcare
• ZF in its $13 billion acquisition of TRW
  
  

Publications

Matt frequently authors articles on topics relating to executive compensation practices and the Section 280G “golden parachute” tax rules. In 2023, Matt co-authored the article, “Usage of Section 280G Gross Ups in Recent M&A Deals,” for The M&A Lawyer. He has also recently co-authored the article “Rise of Merger of Equal Deals” and “Prevalence of Section 280G Gross Ups in Recent M&A Deals” for The M&A Lawyer and “CEO Mega Grant Practices” and “Section 208G: The Law and Lore of the Golden Parachute Excise Tax (Parts I and II)” in Journal of Compensation and Benefits.